title: Decrease of skin infiltrating and circulating CCR10+ T cells coincides with clinical improvement after topical tacrolimus in Omenn syndrome.
authors.forename: Claudia M
authors.initials: CM
authors.lastname: Faaij
authors.forename: Nicola E
authors.initials: NE
authors.lastname: Annels
authors.forename: Geertje
authors.initials: G
authors.lastname: Ruigrok
authors.forename: Mirjam
authors.initials: M
authors.lastname: van der Burg
authors.forename: Lynne M
authors.initials: LM
authors.lastname: Ball
authors.forename: Robbert G
authors.initials: RG
authors.lastname: Bredius
authors.forename: Maarten J
authors.initials: MJ
authors.lastname: van Tol
authors.forename: Arjan C
authors.initials: AC
authors.lastname: Lankester
mesh_terms: D000287:Administration, Topical; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D054447:Receptors, CCR10 / Q000378:metabolism; D016511:Severe Combined Immunodeficiency / Q000188:drug therapy* / Q000276:immunology*; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D016559:Tacrolimus / Q000494:pharmacology*; D016896:Treatment Outcome
chemical_list: C515706:CCR10 protein, human; D007166:Immunosuppressive Agents; D054447:Receptors, CCR10; D016559:Tacrolimus